The clinical significance of axillary lymph node micrometastases in breast cancer

European Journal of Surgical Oncology

Volumn 30, Issue 8, 2004, Pages 807-816

  Sakorafas, George H ^a   Geraghty, J ^b   Pavlakis, G ^a  

^a 251 GENERAL AIR FORCE HOSPITAL   (Greece)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Axillary lymph node dissection; Breast cancer; Lymph node; Metastasis; Micrometastases; Occult metastases; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER RESEARCH; CANCER STAGING; CANCER TISSUE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE BIOPSY; TREATMENT INDICATION;

EID: 4444367542     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.06.020     Document Type: Article

References (97)

1. A. Jemal T. Murray A. Samuels et al. Cancer statistics, 2003 CA Cancer J Clin 53 2003 5-26
2. R.W. Carlson B.O. Anderson W. Bensinger et al. NCCN practice guidelines for breast cancer Oncology 14 2000 33-49
3. A. Goldhirsch J.H. Glick R.D. Gelber et al. Highlights: international consensus panel on the treatment of breast cancer J Clin Oncol 19 2001 3817-3827
4. P.P. Rosen P. Saigo O. Braun Jr. et al. Predictors of recurrence in Stage I (T1 N1 MO) breast carcinoma Ann Surg 193 1981 15-20
5. B. Fisher C. Redmond N. Dimitrov et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors N Engl J Med 320 1989 473-478
6. B. Fisher J. Constantino C. Redmond et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors N Engl J Med 320 1989 479-484
7. E.G. Mansour R. Gray A.H. Shatila et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: an inter-group study N Engl J Med 320 1989 485-490
8. The Ludwig Breast Cancer Study Group Prolonged disease-free survival after a course of perioperative adjuvant chemotherapy for node-negative breast cancer N Engl J Med 320 1989 491-496
9. G.M. Clark Prognostic factor integration Breast Cancer Res Treat 22 1992 185-294
10. Early Breast Cancer Trialist's Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31.000 recurrences and 24.000 deaths among 75.000 women Lancet 339 8785 1992 71-85
11. A. Goldhirsch M. Castiglione R.D. Gelber The International Breast Cancer Study Group A single perioperative course for node-negative breast cancer: five-year results of trial V Monogr Natl Cancer Inst 11 1992 89-96
12. National Cancer Institute Alert on node-negative breast cancer Breast Cancer Res Treat 12 1988 3-5
13. B. Fisher C. Redmond The National Surgical Adjuvant Breast and Bowel Project. Systemic therapy in node-negative patients; updated findings from NSABP clinical trials Monogr Natl Cancer Inst 11 1992 105-116
14. A. Goldhirsch R.D. Gelber R.J. Simes P. Glasziou A.S. Coates The Ludwig Breast Cancer Study Group Costs and benefits of adjuvant therapy in breast cancer: a quality adjusted survival analysis J Clin Oncol 7 1989 36-44
15. W.L. McGuire A.K. Tandon D.C. Alired et al. Treatment decisions in axillary node-negative breast cancer patients Monogr Natl Cancer Inst 1992 173-180
16. S.E. Singletary C. Allred P. Ashley et al. Staging system for breast cancer: revision for the 6th edition of the AJCC Cancer Staging Manual Surg Clin North Am 83 2003 803-819
17. W.C. Liang B.J. Sickle-Santanello T.A. Nims Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 182 2001 365-368
18. M.M. Steinhoff Axillary node micrometastases: detection and biologic significance Breast J 5 1999 325-329
19. A.G. Huvos R. Hutter J.W. Berg Significance of axillary macrometastases and micrometastases in mammary cancer Ann Surg 173 1971 44-46
20. I.A. Nasser A. Lee S. Bosari R. Saganich G. Heatley M.L. Silverman Occult axillary lymph node metastases in 'node-negative' breast carcinoma Hum Pathol 24 1993 950-957
21. R.B. Black M. Roberts H.J. Stewart R. Prescott E.I. Cant M.D. Sumerling The search for occult metastases in breast cancer: does it add to established staging methods? Aust NZ J Surg 50 1980 574-579
22. P.K. Lilleng B.O. Maehle F. Hartveit The size of a micrometastasis in the axilla in breast cancer: a study of nodal tumor-load related to prognosis Eur J Gynecol Oncol 19 1998 220-224
23. F. Hartveit P.K. Lilleng Breast cancer: two micrometastatic variants in the axilla that differ in prognosis Histopathology 28 1996 241-246
24. Greene F.L. Page D.L. Fleming I.D. et al. AJCC cancer staging manual 6th ed. New York: Springer 2002
25. E.J. Wilkinson L. Hause Probability in lymph node sectioning Cancer 33 1974 1269-1274
26. O. Saphir G.D. Amromin Obscure axillary lymph node metastases in carcinoma of the breast Cancer 1 1948 238-241
27. J.W. Pickren Significance of occult metastasis: a study of breast cancer Cancer 14 1961 1266-1271
28. M. De Mascarell M. Trojani G. Abadjian et al. Ganglions axillaires dans les cancers du sein: comparaison des techniques d' analyse histologique standard et en coupes macroscopiquement seriees Bull Cancer (Paris) 69 1992 451-455
29. K. Dowlatshahi M. Fan H.C. Snider F.A. Habib Lymph node micrometastases for breast carcinoma Cancer 80 1997 1188-1197
30. E.J. Wilkinson L. Hause R.G. Hoffman et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases Pathol Ann 17 Pt 2 1982 67-91
31. E.R. Fisher S.J. Swamidoss C.H. Lee H. Rockette C. Redmond B. Fisher Detection and significance of occult axillary node metastases in patients with invasive breast cancer Cancer 42 1978 2025-2031
32. E.R. Fisher A. Palekar H. Rockette C. Redmond B. Fisher Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (Protocol # 4). Significance of axillary nodal micro- and macrometastases Cancer 42 1978 2032-2038
33. P.P. Rosen P. Saigo E. Weathers A.A. Fracchia D.W. Kinne Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size Ann Surg 194 1981 585-591
34. P.P. Rosen P. Saigo O.N. Braun Jr E.J. Beattie Jr D.W. Kinne Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli Am J Surg Pathol 6 1982 639-641
35. S. Friedman F. Bertin H. Mouriesse A. Benchabat J. Genin D. Sarrazin Importance of tumor cells in axillary node sinus margins (clandestine metastases) discovered by serial sectioning in operable breast cancer Acta Oncol 27 1988 483-487
36. International (Ludwig) Breast Cancer Study Group Prognostic importance of occult axillary lymph node micrometastases from breast cancer Lancet 335 1990 1565-1568
37. A.M. Neville Are breast cancer micrometastases worth detecting? J Pathol 161 1990 283-284
38. I. de Mascarel F. Bonichon J.M. Coindre M. Trojani Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up Br J Cancer 66 1992 523-527
39. Z.L. Chen D.R. Wen W.F. Coulson et al. Occult metastases in the axillary lymph nodes of patients with breast cancer node-negative by clinical and histologic examination and conventional histology Dis Markers 9 1991 238-248
40. S.E. Clare S.F. Sener W. Wilkens et al. Prognostic significance of occult lymph node metastases in node-negative breast cancer Ann Surg Oncol 4 1997 447-451
41. C.A.J. Wells A. Heryet J. Brochier K.C. Gatter O.G. Mason The immunohistochemical detection of axillary micrometastases in breast cancer Br J Cancer 50 1984 193-197
42. M. Trojani I. de Mascarel F. Bonichon J.M. Coindre G. Delsol Micrometastases to axillary lymph nodes from carcinoma of the breast Br J Cancer 55 1987 303-306
43. J. Byrne R. Waldron D. McAvinchey P. Dervan The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases Eur J Surg Oncol 13 1987 409-411
44. R.J.J. Springall E. Rytina R.R. Millis Incidence and significance of micrometastases in axillary lymph nodes detected by immunohistochemical techniques J Pathol 160 1990 174A
45. J. Byrne P. Horgan S.S. England J. Callaghan H.F. Given A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast cancer Eur J Surg 28 1992 658-660
46. C.E. Eison D. Kuffe W.W. Johnson Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma Anal Quant Cytol Histol 15 1993 171-178
47. M. Trojani I. de Mascarel J.M. Coindre G. Delsol Micrometastases to axillary lymph nodes from invasive lobular carcinoma of the breast: detection by immunohistochemistry and prognostic significance Br J Cancer 56 1987 838-839
48. G. Bussolati P. Gugliotta I. Morra et al. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast Br J Cancer 54 1986 631-636
49. N. Berry O.B. Jones R. Marshall J. Smallwood L. Taylor Comparison of the detection of breast metastases by routine histological diagnosis and by immunohistochemical staining Eur J Surg Res 20 1988 225-232
50. P.I. Hainsworth J.J. Thandra R.G. Stillwell et al. Detection and significance of occult metastases in node-negative breast cancer Br J Surg 80 1993 459-463
51. D.D. Senmak T.A. Meineka D.S. Knechtges et al. Prognostic significance of cytokeratin-positive breast cancer metastases Mod Pathol 2 1989 516-520
52. A.E. Giulano P.S. Dale R.R. Turner et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg 222 1995 394-401
53. K.U. Chu R.R. Turner N.M. Hansen et al. Sentinel metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable non-sentinel node metastasis Ann Surg Oncol 6 1999 756-761
54. D. Weaver Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am J Surg Pathol 27 2003 842-845
55. D.W. Eldow D. Carter Heterotopic epithelium in axillary lymph nodes: report of a case and review of the literature Am J Clin Pathol 59 1973 666-673
56. P.J. Holdsworth J.M. Hopkinson S.H. Leveson Benign axillary epithelial lymph node inclusion - a histological pitfall Histopathology 13 1988 226-228
57. C. Doglioni P. Dell' Orto G. Zanetti Cytokeratin - immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study Virchows Arch A Pathol Anat Histopathol 416 1990 479-490
58. D.L. Weaver D.N. Krag E.A. Manna et al. Comparison of occult micrometastasis detection in breast cancer sentinel lymph nodes using manual cytokeratin immunohistochemistry and image analysis [abstract 221] Mod Pathol 15 2002 55A-56A
59. M. Mori K. Mimor H. Inove et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase polymerase chain reaction Cancer Res 55 1995 3417-3420
60. S. Noguchi R. Aihara S. Nakamor et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse-transcriptase polymerase chain reaction Cancer 74 1994 1595-1600
61. M.A. Lockett P.I. Baron P.H. O'Brien et al. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel J Am Coll Surg 187 1998 9-16
62. A. Schoenfeld Y. Luqmani D. Smith et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction Cancer Res 54 1994 2986-2990
63. S. Noguchi R. Aihara S. Nakamor The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse-transcriptase polymerase chain reaction: comparison between muc-1 mRNA and keratin-19mRNA amplification Am J Pathol 148 1996 649-656
64. A. Schoenfeld Y. Luqmani H.O. Sinnett et al. Keratin 19mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients Br J Cancer 74 1996 1639-1642
65. S. Noguchi R. Aihara K. Motamura et al. Histological characteristics of breast cancer patients with occult lymph node metastases detected by keratin 19mRNA reverse transcriptase-polymerase chain reaction Cancer 78 1996 1235-1240
66. D.S.B. Hoon F. Doi A.E. Giulano P. Schmid A.J. Conrad The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction Cancer 76 1995 533-534
67. P. Watson J. Safneck K. Lee et al. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastases J Natl Cancer Inst 85 1993 902-907
68. E. Berns J. Foekens I. van Staveren et al. Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment Gene 159 1995 11-18
69. D.S.B. Hoon T. Sarantou F. Doi et al. Detection of metastatic breast cancer by β-HCG polymerase chain reaction Int J Cancer (Pred Oncol) 69 1996 369-374
70. A. Pagani A. Sapino V. Eusebi et al. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinoma of the breast Virchows Arch 425 1994 459-465
71. J. Clark R. Shiu F. Orr P. Watson Reverse transcriptase polymerase chain reaction assay for prolactin-inducible protein gene expression to detect human breast cancer micrometastases Proc Natl Acad Sci 37 1996 86-87
72. M. Mitas K. Mikhitarian C. Walters et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel Int J Cancer 93 2001 162-171
73. M. Ishida K. Kitamura J. Kinoshita et al. Detection of micrometastasis in the sentinel lymph nodes in breast cancer Br J Surg 89 2002 86-89
74. G.J. Liefers Tollenaar A.M. Cleton-Jansen Molecular detection of minimal residual disease in colorectal and breast cancer Histopathology 34 1999 385-390
75. F.F. Attiyeh M. Jensen A.G. Huvos A. Fracchia Axillary micrometastases and macrometastases in carcinoma of the breast Surg Gynecol Obstet 144 1977 839-842
76. American Joint Committee on Cancer (AJCC). Cancer staging manual 5th ed. Philadelphia: Lippincott-Raven Ed; 1997 p. 174
77. R.J. Cote P.P. Rosen M.I. Lesser L.J. Old M.P. Osborne Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases J Clin Oncol 9 1991 1749-1756
78. I.J. Diel M. Kaufmann S.D. Costa et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status J Natl Cancer Inst 88 1996 1652-1658
79. A.M. Neville K. Price R.D. Gelber A. Goldhirsch Axillary node micrometastases and breast cancer Lancet 337 1991 1110
80. M.A. McGurkin M.C. Cummings M.O. Walsh et al. Occult axillary lymph node metastases in breast cancer: their detection and prognostic significance Br J Cancer 73 1996 88-95
81. Carlson R.W. Clinical implications of lymph node and bone marrow micrometastases in breast cancer American Society of Clinical Oncology educational book 2003 p. 561-565
82. K.U. Chu R.R. Turner N.M. Hansen et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229 1999 536-541
83. R.J. Cote H.F. Peterson B. Chaiwun et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group Lancet 354 9182 1999 896-900
84. N.M. Hansen B.J. Grube W. Te et al. Clinical significance of axillary micrometastases in breast cancer; how small is too stall [abstract 91] Proc ASCO 20 2001 249
85. P.L. Fotzgibbons D.L. Page D. Weaver et al. Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 2000 966-978
86. P.J. Bostick K.T. Huynh T. Sarantou et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple marker RT -PCR Int J Cancer 79 1998 645-651
87. G.H. Sakorafas A.G. Tsiotou Sentinel lymph node biopsy in breast cancer Am Surg 66 2000 667-674
88. G.H. Sakorafas D.R. Farley Breast conservation therapy for breast cancer; atlas of therapeutic intervention, monograph (e-book). 2003 Digital Content S.A. Athens www.e-bookshop.gr p. 120
89. G. Viale E. Maiorano G. Mazzarol et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma Cancer 92 2001 1378-1384
90. R.R. Turner K.U. Chu K. Qi et al. Pathologic features associated with non-sentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node Cancer 89 2000 574-581
91. N. Chua O. Ung R. Taylor et al. Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma Cancer 92 2001 1769-1774
92. B.J. Czerniecki A.M. Scheff L.S. Callans et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma Cancer 85 1999 1098-1103
93. C. Reynolds J. Mick J. Donohue et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17 1999 1720-1726
94. M.R. Weiser L.L. Mongromer L.K. Tan et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes Ann Surg Oncol 8 2000 145-149
95. S.E. Singletary Systemic treatment following sentinel lymph node biopsy in breast cancer: who, what, and why? J Am Coll Surg 192 2001 220-230
96. M. Noguchi Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes Br J Surg 89 2002 1505-1515
97. T.J. Yeatman C.E. Cox The significance of breast cancer lymph node micrometastases Surg Oncol Clin North Am 83 1999 481-496